Trial intelligence / Profile preview

Remdesivir vs Remdesivir + Ivermectin in Severe COVID-19

NCT04944082Phase 4Unknown

Sponsor
Assiut University
Start
Jul 2021
Primary completion
Dec 2021
Modality
Small Molecules
01

Overview

A Phase 4 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Assiut University. Status: unknown.

02

Drugs

CHILD-IVITAB
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04944082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04944082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call